In the phase III ARISE trial, adjunctive xanomeline and trospium chloride (Cobenfy) were no better than placebo at improving ...

Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a keenly ...

(Reuters) -Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a ...

Mustapha Bundu scores twice and sets up a third as Plymouth keep alive their survival hopes alive with victory over Coventry.

Coventry City head coach Frank Lampard is left to rue his side's mistakes as they lose 3-1 at bottom-of-the-table Plymouth ...

Bristol Myers Squibb Co.’s treatment for schizophrenia failed in a study designed to expand its use, denting the company’s ...

The Heights Libraries Board of Trustees has allowed VanLear to lease some storage space in the old Coventry PEACE campus, ...

Cobenfy (xanomeline and trospium chloride) as an adjunctive treatment to atypical antipsychotics demonstrated a 2.0-point ...

A 21,000-square-foot commercial center recently sold for $9.22 million, according to public records. Coventry Crossing, ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

Cobenfy’s late-stage flop is BMS’ second high-profile failure in as many weeks. The pharma announced last week that Camzyos ...

In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with ...